CH0012005267
CH0012005267
NOVARTIS N
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 226.38B EUR | 240.59B EUR | 230.61B EUR | 209.13B EUR |
Enterprise Value | 265.55B EUR | 281.99B EUR | 270.73B EUR | 233.07B EUR |
Valuation Multiples | ||||
Trailing P/E | 22.69x | 18.86x | 17.04x | 20.15x |
Forward P/E | 14.53x | -- | -- | -- |
Price to Sales | 3.99x | 4.24x | 4.08x | 4.86x |
Price to Book | 6.55x | 5.79x | 5.99x | 4.53x |
EV/Revenue | 4.68x | 4.97x | 4.79x | 5.41x |
EV/EBITDA | 11.5x | 12.56x | 12.09x | 13.72x |
Price to FCF (P/FCF) | 19.02x | 16.06x | 14.45x | 15.97x |
EV/FCF | 22.31x | 18.82x | 16.96x | 17.8x |
FCF Yield | 5.26% | 6.23% | 6.92% | 6.26% |